AnaptysBio, Inc. (ANAB)

Healthcare · Biotechnology · NASDAQ

AnaptysBio, Inc. (ANAB) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.68B and a free-cash-flow yield of 1.2%. Over the most recent reported fiscal year, revenue grew 157.0%.

Market cap	$1.68B
Trailing P/E	—
FCF yield	1.2%
Revenue growth (YoY)	+157.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ANAB data on Nama Insights →